Recently, Wondfo Biotech received the confirmation letter of in vitro diagnostic pre-qualification (PQ) issued by the World Health Organization (WHO). Recommended purchase list.

WHO PQ certification is an important threshold for the procurement of medicines and in vitro diagnostic products by international organizations such as the World Health Organization, UNICEF, and the Global Fund. On the basis of the original professional version, the Wondfo Bio-AIDS testing product has added the form of self-testing product, which is convenient for individuals and families to carry out auxiliary diagnosis and daily monitoring of HIV, and provides strong support and guarantee for the global AIDS prevention and control.

As early as 2002, Wondfo Biotech launched the first HIV detection reagent, and then continued to research key problems, innovate and continuously enrich the queue of HIV rapid detection products. Relevant technical achievements and products have been widely recognized and widely used in more than 50 countries and regions around the world, serving hundreds of millions of people.

On November 29, 2018, the professional version of Wondfo Bio-AIDS test passed the PQ certification of the World Health Organization; on July 13, 2022, the Wondfo Bio-AIDS self-test product obtained the PQ certification of the WHO. The performance of HIV testing products and the company's quality system were once again recognized by the World Health Organization.